Aro Biotherapeutics Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Philadelphia, USA
Description - Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases.
Tags - Centyrin RNA
Team
Founder Susan Dillon
Founder
Funding
Aro Biotherapeutics raised $88,000,000 with Northpond Ventures and Cowen Healthcare Investments and BVF Partners L, Ridgeback Capital, Johnson & Johnson Innovation, HealthCap - 1/5/2021